AU2002233822A1 - Oral itraconazole formulations and methods of making the same - Google Patents

Oral itraconazole formulations and methods of making the same

Info

Publication number
AU2002233822A1
AU2002233822A1 AU2002233822A AU2002233822A AU2002233822A1 AU 2002233822 A1 AU2002233822 A1 AU 2002233822A1 AU 2002233822 A AU2002233822 A AU 2002233822A AU 2002233822 A AU2002233822 A AU 2002233822A AU 2002233822 A1 AU2002233822 A1 AU 2002233822A1
Authority
AU
Australia
Prior art keywords
itraconazole
methods
acid
working solution
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002233822A
Other languages
English (en)
Inventor
John Elgin Kerr
Ranga Raju Namburi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of AU2002233822A1 publication Critical patent/AU2002233822A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2002233822A 2001-02-06 2002-02-01 Oral itraconazole formulations and methods of making the same Abandoned AU2002233822A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26665301P 2001-02-06 2001-02-06
US60/266,653 2001-02-06
US09/933,032 US6663897B2 (en) 2001-02-06 2001-08-20 Oral itraconazole formulations and methods of making the same
US09/933,032 2001-08-20
PCT/NL2002/000080 WO2002062318A2 (en) 2001-02-06 2002-02-01 Oral itraconazole formulations and methods of making the same

Publications (1)

Publication Number Publication Date
AU2002233822A1 true AU2002233822A1 (en) 2002-08-19

Family

ID=26951964

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002233822A Abandoned AU2002233822A1 (en) 2001-02-06 2002-02-01 Oral itraconazole formulations and methods of making the same

Country Status (9)

Country Link
US (1) US6663897B2 (https=)
EP (1) EP1357899B1 (https=)
JP (1) JP2004521897A (https=)
AT (1) ATE369840T1 (https=)
AU (1) AU2002233822A1 (https=)
CA (1) CA2437372A1 (https=)
DE (1) DE60221795T2 (https=)
MX (1) MXPA03006980A (https=)
WO (1) WO2002062318A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015239D0 (en) * 2000-06-21 2000-08-16 Biochemie Gmbh Organic compounds
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
US20040115266A1 (en) * 2002-02-01 2004-06-17 Namburi Ranga Raju Oral itraconazole formulations and methods of making the same
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7446107B2 (en) 2002-02-15 2008-11-04 Transform Pharmaceuticals, Inc. Crystalline forms of conazoles and methods of making and using the same
WO2004000284A1 (en) 2002-06-21 2003-12-31 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
CA2477923C (en) 2002-03-01 2021-02-23 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
EP1511490A4 (en) 2002-05-31 2009-03-11 Transform Pharmaceuticals Inc NOVEL CONAZOLE CRYSTALLINE FORMS AND RELATED METHODS, PHARMACEUTICAL COMPOSITIONS AND METHODS
EP1539111A1 (en) * 2002-08-05 2005-06-15 DSM IP Assets B.V. Oral dosage forms of water insoluble drugs and methods of making the same
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US20050074494A1 (en) * 2003-10-06 2005-04-07 Xiu-Xiu Cheng Itraconazole immediate release formulation
US20050118265A1 (en) * 2003-11-28 2005-06-02 Anandi Krishnan Antifungal oral dosage forms and the methods for preparation
GB0612695D0 (en) * 2006-06-27 2006-08-09 Univ Gent Process for preparing a solid dosage form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791111A (en) 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IT1263831B (it) 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
CA2258683C (en) * 1996-06-28 2007-07-31 Schering Corporation Oral composition comprising a triazole antifungal compound
FR2758461A1 (fr) 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
JP3608800B2 (ja) * 1997-03-26 2005-01-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗真菌剤およびポリマーでコートされたコアを有するペレット剤
BR9906712A (pt) * 1998-07-17 2000-10-10 Janssen Pharmaceutica Nv Péletes que apresentam um núcleo revestido com um antifúngico e um polìmero
SK288117B6 (sk) 1998-11-20 2013-09-03 Skyepharma Canada Inc. Rapidly dispersing solid dry therapeutic dosage form
ES2251985T3 (es) 1999-03-24 2006-05-16 R.P. Scherer Technologies, Inc. Particula granulada para mejorar la solubilidad acuosa de farmacos, y su procedimiento de preparacion.
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
KR100331529B1 (ko) 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법

Also Published As

Publication number Publication date
US6663897B2 (en) 2003-12-16
MXPA03006980A (es) 2004-10-15
DE60221795D1 (de) 2007-09-27
JP2004521897A (ja) 2004-07-22
EP1357899A2 (en) 2003-11-05
EP1357899B1 (en) 2007-08-15
WO2002062318A3 (en) 2002-11-21
WO2002062318A2 (en) 2002-08-15
ATE369840T1 (de) 2007-09-15
DE60221795T2 (de) 2007-12-27
US20020150620A1 (en) 2002-10-17
CA2437372A1 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
AU2002233822A1 (en) Oral itraconazole formulations and methods of making the same
MX9405217A (es) Proceso para la fabricacion de sal de magnesio de omeprazol, productoobtenido a partir del mismo y composicion farmaceutica que contiene dichoproducto.
ATE355829T1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
CA2408848A1 (en) Rapidly disintegrating solid oral dosage form
WO2004000235A3 (en) Breath freshening and oral cleansing product with magnolia bark extract
CA2468741A1 (en) Acid soluble, high fluid loss pill for lost circulation
DE50110049D1 (de) Magnesium-ammonium-phosphat-zemente, deren herstellung und verwendung
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
DE69936430D1 (de) Verfahren zur Herstellung von in der Mundhöhle rasch zerfallenden Tabletten
AR029546A1 (es) Particulas farmaceuticas con sabor enmascarado
ES2153498T3 (es) Proceso para preparar formas de dosificacion farmaceutica solidas.
WO2002007772A3 (en) Improved oral dosage formulations
DZ3384A1 (fr) Procede d'obtention de formulations aqueuses de principes actifs sensibles a l'oxydation
HUP0000141A2 (hu) Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására
PL370446A1 (en) Pharmaceutical formulation, its use, and method for its manufacture
CA2419314A1 (en) Preparation of risperidone
HK1052872A1 (zh) 微团
WO2002043706A3 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
AU3657100A (en) Use of water-soluble beta-(1,3) glucans as agents for producing therapeutic skintreatment agents
CA2429639A1 (en) Stable azithromycin monohydrate
WO2001058875A3 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
NO20004919L (no) Fremgangsmåte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
HUP0302310A3 (en) Novel formulations of alpha-2,4-disulfophenyl-n-tert-butylnitrone and process for their preparation
CA2399709A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
EP1842532A3 (en) Oral sparingly water-soluble antifungal formulations and methods of making the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase